Healthcare Sector Comment – November 2016

On 9th November 2016, Donald Trump became the 45th US President-Elect, so what does this mean for the healthcare M&A market? First, during campaigning Trump promised to cut down on tax inversion M&A, which avoids US corporate taxes on

Find out more...

Healthcare Sector Comment – October 2016

Biotech/Biopharma companies are seeing a resurgence of M&A activity as we near the end of the year, despite the negative media attention around drug pricing, political pressure and tighter healthcare budgets – driven by the following: several biotech drugs

Find out more...

Real Estate Sector Comment – October 2016

Sale and leaseback analysis At Clearwater International we estimate that less than half of European companies own their real estate. While interest rates remain at a historical low, a growing number of investors are beginning to wonder whether the

Find out more...

Healthcare Sector Comment – September 2016

Increasing incidences of lifestyle related diseases like obesity and diabetes are driving growth in the devices market, especially with disorders of the eye including glaucoma, diabetic retinopathy and cataracts. Problems such as these can also be prevalent among an

Find out more...

Consumer Sector Comment – September 2016

A store within a store, a concept far from new, however one that has made headlines recently. Last month, the world’s second largest retailer Tesco, announced its store-in-store partnership with UK health food chain Holland & Barrett, subsidiary of

Find out more...